NO20073942L - Farmasoytiske sammensetninger for behandling av sykdommer assosiert med NF-KB-aktivitet - Google Patents
Farmasoytiske sammensetninger for behandling av sykdommer assosiert med NF-KB-aktivitetInfo
- Publication number
- NO20073942L NO20073942L NO20073942A NO20073942A NO20073942L NO 20073942 L NO20073942 L NO 20073942L NO 20073942 A NO20073942 A NO 20073942A NO 20073942 A NO20073942 A NO 20073942A NO 20073942 L NO20073942 L NO 20073942L
- Authority
- NO
- Norway
- Prior art keywords
- activity
- treatment
- pharmaceutical compositions
- diseases associated
- effected
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 102000003945 NF-kappa B Human genes 0.000 title 1
- 108010057466 NF-kappa B Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL16600604A IL166006A0 (en) | 2004-12-27 | 2004-12-27 | Pharmaceutical compositions for treating diseases associated with nf-kb activity |
| PCT/IL2005/001335 WO2006070348A1 (en) | 2004-12-27 | 2005-12-11 | PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-κB ACTIVITY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073942L true NO20073942L (no) | 2007-09-27 |
Family
ID=36072106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073942A NO20073942L (no) | 2004-12-27 | 2007-07-27 | Farmasoytiske sammensetninger for behandling av sykdommer assosiert med NF-KB-aktivitet |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8338567B2 (enExample) |
| EP (1) | EP1838347B1 (enExample) |
| JP (1) | JP5686940B2 (enExample) |
| AU (1) | AU2005320905B2 (enExample) |
| CA (1) | CA2593035C (enExample) |
| ES (1) | ES2518340T3 (enExample) |
| IL (2) | IL166006A0 (enExample) |
| NO (1) | NO20073942L (enExample) |
| WO (1) | WO2006070348A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5954728B2 (ja) | 2010-01-22 | 2016-07-20 | 国立研究開発法人科学技術振興機構 | 蛋白質の分解活性を測定するためのプローブ試薬 |
| EP3431493A1 (en) * | 2013-09-03 | 2019-01-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for inducing senescence in cancer |
| WO2018085208A1 (en) | 2016-11-02 | 2018-05-11 | The Research Foundation For The State University Of New York | Methods of inhibiting viruses using compositions targeting tsg101-ubiquitin interaction |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4036945A (en) | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
| US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
| US5843721A (en) | 1997-07-03 | 1998-12-01 | Tularik Inc. | Nucleic acids encoding human NIK protein |
| US6265538B1 (en) * | 1998-02-27 | 2001-07-24 | The Regents Of The University Of California | Inhibitor of the inflammatory response induced by the TNFA and IL-1 |
| ITMI20010402U1 (it) | 2001-07-18 | 2003-01-18 | Valerio Leccacorvi | Rivestimento per le superfici di una piscina |
| ATE521707T1 (de) * | 2002-04-18 | 2011-09-15 | Yeda Res & Dev | Derivate eines nf-kappab induzierenden enzyms, verfahren zur herstellung der derivate und deren verwendung |
-
2004
- 2004-12-27 IL IL16600604A patent/IL166006A0/xx unknown
-
2005
- 2005-12-11 EP EP05838184.9A patent/EP1838347B1/en not_active Expired - Lifetime
- 2005-12-11 WO PCT/IL2005/001335 patent/WO2006070348A1/en not_active Ceased
- 2005-12-11 JP JP2007547787A patent/JP5686940B2/ja not_active Expired - Fee Related
- 2005-12-11 ES ES05838184.9T patent/ES2518340T3/es not_active Expired - Lifetime
- 2005-12-11 AU AU2005320905A patent/AU2005320905B2/en not_active Ceased
- 2005-12-11 CA CA2593035A patent/CA2593035C/en not_active Expired - Fee Related
- 2005-12-11 US US11/722,898 patent/US8338567B2/en not_active Expired - Fee Related
-
2007
- 2007-06-14 IL IL183926A patent/IL183926A/en not_active IP Right Cessation
- 2007-07-27 NO NO20073942A patent/NO20073942L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP5686940B2 (ja) | 2015-03-18 |
| JP2008525427A (ja) | 2008-07-17 |
| US20090098106A1 (en) | 2009-04-16 |
| IL183926A0 (en) | 2007-10-31 |
| ES2518340T3 (es) | 2014-11-05 |
| CA2593035A1 (en) | 2006-07-06 |
| AU2005320905B2 (en) | 2011-03-17 |
| US8338567B2 (en) | 2012-12-25 |
| IL183926A (en) | 2012-02-29 |
| EP1838347A1 (en) | 2007-10-03 |
| AU2005320905A1 (en) | 2006-07-06 |
| WO2006070348A1 (en) | 2006-07-06 |
| IL166006A0 (en) | 2006-01-15 |
| CA2593035C (en) | 2014-10-14 |
| EP1838347B1 (en) | 2014-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
| NO20073699L (no) | Stabile protaglandin-inneholdende preparater | |
| EA200971053A1 (ru) | Способы лечения кожных язв | |
| NO20083885L (no) | Fremgangsmate for behandling av inflammatoriske sykdommer | |
| NO20071243L (no) | Substituterte biarylpiperazinylpyridinanaloger. | |
| ATE429430T1 (de) | Stoffwechselmodulatoren und behandlung damit verbundener erkrankungen | |
| EA200600414A1 (ru) | ПРОИЗВОДНЫЕ БОРОНОВОЙ КИСЛОТЫ (ВАРИАНТЫ), ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, КОМПОЗИЦИЯ ДЛЯ ИНГИБИРОВАНИЯ АКТИВНОСТИ NF-kB И ДЕГРАДАЦИИ БЕЛКА И СПОСОБЫ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ (ВАРИАНТЫ) | |
| EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
| NO20064186L (no) | Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod | |
| NO20053678L (no) | Kombinasjonsterapi for behandling av immuninflammatoriske forstyrrelser | |
| NO20055129L (no) | Fenylsubstituerte karboksylsyrer | |
| NO20090469L (no) | Substituerte piperidiner som oker P53-aktiviteten, og anvendelse derav | |
| AR049955A1 (es) | Composiciones y metodos para el tratamiento de trastornos metabolicos | |
| UY32591A (es) | Inhibidores ciclicos de 11beta-hidroxiesteroide deshidrogenasa 1 | |
| NO20073456L (no) | Omega-3 fettsyrer og dyslipidemisk middel for lipidbehandling | |
| IN2015DN00376A (enExample) | ||
| DK1651161T3 (da) | Farmaceutiske præparater og fremgangsmåder til at fremme sårheling | |
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| NO20084542L (no) | Farmasoytisk kombinasjon inneholdende 3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol og paracetamol | |
| AR056824A1 (es) | Tableta de neramexano con matriz de liberacion modificada | |
| DK1296972T3 (da) | Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer | |
| NO20092473L (no) | Kombinasjon | |
| EA200600921A1 (ru) | Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний | |
| BRPI0507048A (pt) | uso de baixa dosagem de eritropoetina para estimular células precursoras endoteliais, regenerar órgãos e retardar a progressão de danos em órgão alvo | |
| CY1111353T1 (el) | Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |